UT 2.5 (Orenitram 2.5 mg)
Generic Name: treprostinil
Pill imprint UT 2.5 has been identified as Orenitram 2.5 mg.
Orenitram is used in the treatment of pulmonary hypertension Treprostinil (Remodulin, Tyvaso): There is no proven risk in humans during pregnancy. Treprostinil oral (Orenitram): Risk cannot be ruled out during pregnancy. Orenitram 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- UT 2.5
- 2.5 mg
- Prescription only
- Pregnancy Category:
- B - No proven risk in humans - treprostinil (Remodulin, Tyvaso)
C - Risk cannot be ruled out - treprostinil oral (Orenitram)
- CSA Schedule:
- Not a controlled drug
- United Therapeutics Corp.
More about Orenitram (treprostinil)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.